ROIV
Roivant Sciences Ltd.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #921
- Final score
- 18.14
- Years on list
- 4
↘ Down 570 since 2023
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 570 since 2023
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | ROIV | BBIO | MDGL |
|---|---|---|---|
| Climate Change | 15.7 | 19.8 | 15.8 |
| Employee Relations | 24.6 | 28.0 | 18.0 |
| Environment | 12.5 | 7.4 | 7.5 |
| Stakeholders & Society | 19.3 | 14.5 | 19.5 |
| Human Rights | 2.5 | 11.8 | 22.2 |
| Governance | 24.7 | 25.9 | 29.7 |
| Performance Rating | 45.8 | 29.0 | 38.3 |